{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:12:27Z","timestamp":1792591947043,"version":"4.5.0"},"reference-count":52,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","award":["BRC648.III.KR.101350"],"award-info":[{"award-number":["BRC648.III.KR.101350"]}],"id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013733","name":"Ipsen Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Neuroendocrinology"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Small intestinal neuroendocrine tumours (SI\u2010NETs) are associated with mesenteric fibrosis, which causes significant morbidity and mortality. Telotristat ethyl was developed to treat carcinoid syndrome in SI\u2010NET patients. Recent studies indicated telotristat ethyl could have anti\u2010tumour activity; however, the mechanism remains unclear. This study aimed to investigate the effects of telotristat ethyl on SI\u2010NET\u2013fibroblast crosstalk in tumour progression and mesenteric fibrosis. A co\u2010culture paracrine model with GOT1 (tumour) cells and LX2 (stromal) cells was optimized. Cells were treated with conditioned medium with\/without telotristat ethyl followed by RNA sequencing and Gene Set Enrichment Analysis. Quantitative RT\u2010PCR, immunohistochemistry, and Western blot were performed on first and second tier targets in tissue from 34 SI\u2010NET patients grouped into categories of mesenteric fibrosis severity. Telotristat ethyl significantly decreased proliferation and serotonin secretion in a dose\u2010dependent manner in GOT1 cells. GSEA data indicated ECM\u2010related reactomes were downregulated in GOT1 cells grown in conditioned medium of LX2 cells with telotristat ethyl.\n                    <jats:italic>LAMA5<\/jats:italic>\n                    ,\n                    <jats:italic>COL6A2<\/jats:italic>\n                    , and\n                    <jats:italic>COL12A1<\/jats:italic>\n                    expression was significantly increased in mild and severely fibrotic patients. Immunohistochemistry determined the localization of proteins such as COL4A2 in the stroma and ADAM12 in tumour cells. Protein analysis of second tier targets showed differences in expression, including \u03b2\u2010catenin, which was significantly upregulated, and pAKT\/AKT, which tended to increase in primary tumour compared to normal SI. Telotristat ethyl affects the expression of genes associated with the ECM and interferes with SI\u2010NET\u2013fibroblast crosstalk. Further analysis is required; however, this study represents an important step in understanding the mechanisms of telotristat ethyl when treating SI\u2010NET patients.\n                  <\/jats:p>","DOI":"10.1111\/jne.70094","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:30:50Z","timestamp":1758846650000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Telotristat ethyl affects tumour\u2010fibroblast crosstalk in small intestinal neuroendocrine tumours"],"prefix":"10.1111","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9498-1961","authenticated-orcid":false,"given":"Harry","family":"Hodgetts","sequence":"first","affiliation":[{"name":"Regenerative Medicine and Fibrosis Group, Institute for Liver and Digestive Health Royal Free Hospital, University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Castanho","family":"Martins","sequence":"additional","affiliation":[{"name":"Regenerative Medicine and Fibrosis Group, Institute for Liver and Digestive Health Royal Free Hospital, University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luohai","family":"Chen","sequence":"additional","affiliation":[{"name":"Regenerative Medicine and Fibrosis Group, Institute for Liver and Digestive Health Royal Free Hospital, University College London  London UK"},{"name":"Neuroendocrine Tumour Unit, ENETS Centre of Excellence Royal Free London NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Hall","sequence":"additional","affiliation":[{"name":"Sheila Sherlock Liver Centre Royal Free London NHS Foundation Trust  London UK"},{"name":"Cellular Pathology Department Royal Free London NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7598-7319","authenticated-orcid":false,"given":"Tu Vinh","family":"Luong","sequence":"additional","affiliation":[{"name":"Regenerative Medicine and Fibrosis Group, Institute for Liver and Digestive Health Royal Free Hospital, University College London  London UK"},{"name":"Sheila Sherlock Liver Centre Royal Free London NHS Foundation Trust  London UK"},{"name":"Cellular Pathology Department Royal Free London NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalvinder","family":"Mandair","sequence":"additional","affiliation":[{"name":"Neuroendocrine Tumour Unit, ENETS Centre of Excellence Royal Free London NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyn","family":"Caplin","sequence":"additional","affiliation":[{"name":"Neuroendocrine Tumour Unit, ENETS Centre of Excellence Royal Free London NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9440-0571","authenticated-orcid":false,"given":"Krista","family":"Rombouts","sequence":"additional","affiliation":[{"name":"Regenerative Medicine and Fibrosis Group, Institute for Liver and Digestive Health Royal Free Hospital, University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0589"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23883"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0380"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v12.i8.791"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2018.54.7.2834460"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.2780"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0455"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1530\/EO-22-0077"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S261257"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S276519"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24533"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1159\/000502200"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0238-1"},{"key":"e_1_2_11_15_1","doi-asserted-by":"crossref","unstructured":"TowDH TranCG BorbonLC et al.Inhibition of serotonin biosynthesis in neuroendocrine neoplasm suppresses tumor growth in vivo.bioRxiv.2023.","DOI":"10.1101\/2023.04.07.536013"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0445e"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64017-5"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.042127"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.629665"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30029"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.01.032"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-94804-7_1"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-013-9597-2"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00667-x"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2010.11.898"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2018.01.019"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22465"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207619"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.347"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2017.11.010"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.12356"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i22.2381"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00114"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-020-05498-0"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179319"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102366"},{"key":"e_1_2_11_37_1","first-page":"4141","article-title":"ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer","volume":"12","author":"Liu YJ","year":"2023","journal-title":"Onco Targets Ther"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14566"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050630"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102610"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2020.03.01"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S194568"},{"key":"e_1_2_11_43_1","first-page":"3103","article-title":"COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer","volume":"20","author":"Jiang X","year":"2019","journal-title":"Mol Med Rep"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01638-3"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-018-0096-9"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1131"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31079"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02107-4"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020345"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgt018"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0020"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18585"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc8188"}],"container-title":["Journal of Neuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jne.70094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T10:34:47Z","timestamp":1763116487000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jne.70094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1111\/jne.70094"],"URL":"https:\/\/doi.org\/10.1111\/jne.70094","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/JNE.70094\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/JNE.70094\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/JNE.70094\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/JNE.70094\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/JNE.70094\/v2\/response1","asserted-by":"object"}]},"ISSN":["0953-8194","1365-2826"],"issn-type":[{"value":"0953-8194","type":"print"},{"value":"1365-2826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"2024-10-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70094"}}